Skip to main content
. 2023 Jan 16;24(2):1738. doi: 10.3390/ijms24021738

Table 3.

Advantages and Disadvantages of the different liquid biopsy sources in relation to CNVs.

ctDNA CTC Extracellular Vesicles
Advantages
Detection of tumor heterogeneity
Offers RNA- and DNA-based measurements
Use of standardized methodology exemplified by CE-IVD platform for enumeration and capturing and ctDNA mutation and methylation assays
Can monitor disease progression and relapse
Disadvantages
Present in low numbers—large amount of sample required
Patient-derived material is specific to a disease stage exemplified by CTC in metastatic disease
Extensive analytic and clinical validity required